Publicacions en què col·labora amb Jose María Mateo Aguado (10)

2013

  1. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

2007

  1. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study

    Transplantation, Vol. 84, Núm. 7, pp. 851-856

2006

  1. An unusual indication for cardiac transplantation: Isolated myocardial tuberculosis

    Journal of Heart and Lung Transplantation, Vol. 25, Núm. 1, pp. 128-130

  2. Valganciclovir preemptive therapy for the prevention of cytomegalovirus disease in high-risk seropositive solid-organ transplant recipients

    Transplantation, Vol. 82, Núm. 1, pp. 30-35

2005

  1. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients

    Transplantation Proceedings

  2. Efficacy and safety of valgancyclovir as preemptive therapy for the prevention of cytomegalovirus disease in solid organ transplant recipients

    Transplantation Proceedings

2000

  1. Aneurisma micótico por Aspergillus en la línea de sutura aórtica tras el trasplante cardíaco

    Revista Espanola de Cardiologia, Vol. 53, Núm. 10, pp. 1403-1405

1999

  1. Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: Is azathioprine a contributory factor?

    Journal of Heart and Lung Transplantation, Vol. 18, Núm. 6, pp. 607-610

1995

  1. Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV- seropositive heart transplant recipients treated with OKT3

    Antimicrobial Agents and Chemotherapy